Table 2 Proportions of the eligible populations with colonoscopy/FOBT, mammography or PSA testing in 2014, 2016, and 2018, and significance tests of change of these proportions, pairwise between years
2014 | 2016 | 2018 | Change in proportion 20,142,016 | pa | Change in proportion 2016–2018 | pa | Change in proportion 2014–2018 | pa | |
|---|---|---|---|---|---|---|---|---|---|
colonoscopy/ FOBTb | 8.3% | 8.9% | 9.2% | 0.7% | < 0.001 | 0.2% | 0.003 | 0.9% | < 0.001 |
mammography | 20.9% | 21.2% | 20.4% | 0.3% | 0.017 | −0.8% | < 0.001 | −0.5% | < 0.001 |
PSA testingc | 30.5% | 31.1% | 31.8% | 0.5% | 0.001 | 0.7% | < 0.001 | 1.2% | < 0.001 |